News
12-13-2010, 04:15 AM
Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer.
More... (http://www.news-medical.net/news/20101213/Exemestane-may-provide-post-surgery-option-for-postmenopausal-women-with-hormone-receptor-positive-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20101213/Exemestane-may-provide-post-surgery-option-for-postmenopausal-women-with-hormone-receptor-positive-breast-cancer.aspx)